Navigation Links
WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
Date:4/3/2013

White Plains, NY (PRWEB) April 03, 2013

WINFertility®, Inc., the leader in Infertility Management Programs for insurers and employers, announced the extension of its consumer offering to two more major cities in Texas, with the addition of RMA of Texas. This marks the ninth Texas location where consumers can access The WINFertility Program. The expansion increases the availability of high quality, affordable
infertility care for many of the over 2 million Texas residents facing infertility today who are without advanced infertility insurance coverage.

WINFertility simplifies, streamlines and discounts fertility treatments for uninsured patients trying to conceive. State-of-the-art, evidence-based treatment programs for IUI, IVF and Third Party Reproduction are delivered by WINFertility’s highly accredited network of fertility specialists. Infertility medications are included in the single-cycle discounted price, and there is no age or medical criteria required to enroll in the program. If treatment is indicated by a participating provider and the patient has no infertility insurance coverage or has exhausted her benefits, she is then eligible to participate in the WINFertility Program.

WINFertility’s FertilityCoach Nurses(SM) are available on a 24/7 basis for education and care coordination, supported by a Medical Advisory Board comprised of industry-leading Reproductive Endocrinologists. Fertility financing programs that provide preferred rates are also available to WINFertility patients.

The WINFertility Treatment Program is now available through RMA of Texas, one of the most successful and fastest growing fertility practices in Central/Southern Texas. Patients can be seen at three convenient offices located throughout the region, as well as via on-line physician consultations.

“We founded RMA of Texas with the conviction that each individual patient has a unique profile that requires a clear understanding of the medical, emotional and financial requirements, as well as careful consideration of each person’s social and ethical values,” stated Francisco Arredondo, MD and Founder. “The WINFertility Treatment Program enables our patients to more easily access and manage the costs of the most appropriate care, so we can help more patients build the family that they are dreaming about. In this challenging economy, it is one more way for us to put the whole patient first.”

More Access for More Patients

“’The Texas Triangle’ is home to almost 75% of the state’s entire population. With the addition of RMA of Texas in San Antonio and Austin, WINFertility is now able to offer our unique program throughout one of the country’s fastest growing regions, where so many struggle with infertility and its associated expenses,” commented Tom Boyajy, COO of WINFertility. “The WINFertility approach is to promote high quality infertility care at a competitive cost. By affiliating with one of the most respected fertility programs in Central/Southern Texas, we are confident that WINFertility patients will be the recipients of both compassionate, patient-centered care and excellent clinical results. Coupled with WINFertility’s proprietary, bundled packages, fertility management expertise, and considerable buying power, we are confident that this newest area of the state can more conveniently receive the very best IVF treatment value possible.”

About WINFertility, Inc.

Founded in 2000, WINFertility is the national leader in Infertility Management Programs, annually managing infertility treatment for many thousands of infertility patients for major insurers and employers. The WINFertility Consumer Program is currently available to serve patients in twenty-two states where a growing number of patients can take advantage of WINFertility’s integrated platform to access evidence-based protocols, high-quality providers and discounts enjoyed only by the largest healthcare purchasers. For more information, visit us at http://www.winfertility.com

Read the full story at http://www.prweb.com/releases/2013/4/prweb10585637.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
2. Reproductive Medicine Associates of New York Now Participating in the WINFertility® Direct-to-Consumer IVF Program
3. Intermittent Hormone Treatment for Prostate Cancer Not the Best
4. Phase 1 ALS trial is first to test antisense treatment of neurodegenerative disease
5. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Introduces New Diet Plans Built Around an Eating Schedule to Produce the Best Weight Loss with Little Effort
6. hCGTreatments / Diet Doc hCG Diets and Weight Loss Plans Offers Dieters 100% prescription grade hCG, manufactured in the U.S. in strict compliance with the FDA
7. hCGTreatments / Diet Doc hCG Diet & Weight Loss Plans Introduces Newly Reformulated Prescription Saffron Extract Diet Pills
8. Fibroids Treatment
9. How “Fibroids Miracle” Helps Women Treat Fibroids Naturally – Vkool.com
10. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Improves All-Natural Diet Pills Slim Down and Ultra Burn
11. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New Tailored Weight Loss for Clients Who Have Been Unsuccessful in the Past
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing effort ... has recently developed and published an informational resource that addresses frequently asked questions. ... common inquiries the site’s team of third party administrator (TPA) contributors regularly receives ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Oily skin is a common and unwelcomed ... Advanced Dermatology has a lot to offer to the discussion of dealing with excess ... is that there are many home remedies that can help remove the oily shine while ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
Breaking Medicine Technology: